These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 7902022

  • 21. Levocabastine eye drops in the treatment of vernal conjunctivitis.
    Goes F, Blockhuys S, Janssens M.
    Doc Ophthalmol; 1994; 87(3):271-81. PubMed ID: 7835196
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Comparison of the efficacy and tolerability of topically administered azelastine, sodium cromoglycate and placebo in the treatment of seasonal allergic conjunctivitis and rhino-conjunctivitis.
    James IG, Campbell LM, Harrison JM, Fell PJ, Ellers-Lenz B, Petzold U.
    Curr Med Res Opin; 2003; 19(4):313-20. PubMed ID: 12841924
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Emedastine ophthalmic solution 0.05% versus levocabastine ophthalmic suspension 0.05% in the treatment of allergic conjunctivitis using the conjunctival allergen challenge model.
    Netland PA, Leahy C, Krenzer KL.
    Am J Ophthalmol; 2000 Dec; 130(6):717-23. PubMed ID: 11124289
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. A double-blind evaluation of topical levocabastine, a new specific H1 antagonist in patients with allergic conjunctivitis.
    Pipkorn U, Bende M, Hedner J, Hedner T.
    Allergy; 1985 Oct; 40(7):491-6. PubMed ID: 2866725
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Intranasal levocabastine for the treatment of seasonal allergic rhinitis: a multicentre, double-blind, placebo-controlled trial.
    Dahl R, Pedersen B, Larsen B.
    Rhinology; 1995 Sep; 33(3):121-5. PubMed ID: 8560160
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Tolerability of levocabastine eye drops.
    Janssens M, Blockhuys S.
    Doc Ophthalmol; 1993 Sep; 84(2):111-8. PubMed ID: 7905376
    [Abstract] [Full Text] [Related]

  • 32. Comparison of azelastine eye drops with levocabastine eye drops in the treatment of seasonal allergic conjunctivitis.
    Giede C, Metzenauer P, Petzold U, Ellers-Lenz B.
    Curr Med Res Opin; 2000 Sep; 16(3):153-63. PubMed ID: 11191004
    [Abstract] [Full Text] [Related]

  • 33. Efficacy and safety of levocabastine nasal spray for seasonal allergic rhinitis.
    Hampel FC, Martin BG, Dolen J, Travers S, Karcher K, Holton D.
    Am J Rhinol; 1999 Sep; 13(1):55-62. PubMed ID: 10088031
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Topical levocabastine, a selective H1 antagonist, in seasonal allergic rhinoconjunctivitis.
    Bende M, Pipkorn U.
    Allergy; 1987 Oct; 42(7):512-5. PubMed ID: 2891316
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. The role of levocabastine in the treatment of allergic rhinoconjunctivitis.
    Knight A.
    Br J Clin Pract; 1994 Oct; 48(3):139-43. PubMed ID: 7913336
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Comparison of effects of topical levocabastine and nedocromil sodium on the early response in a conjunctival provocation test with allergen.
    Hammann C, Kämmerer R, Gerber M, Spertini F.
    J Allergy Clin Immunol; 1996 Dec; 98(6 Pt 1):1045-50. PubMed ID: 8977503
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.